All Updates - Evidence to Practice.

Theme: Evidence to Action: Protocolizing Emergency Care Across India

Scientific Programme

Conference Schedule

Conference Schedule

TIME TOPIC SPEAKERS CHAIRPERSONS
08:00 - 09:00 am Breakfast & Poster Presentation
SESSION 1 — TRAUMA: UPDATES 2026
09:00 - 09:15 am ATLS 11th Edition (2025) —
The xABCDE Revolution: Why
Haemorrhage Control Now Comes
Before Airway; New Permissive
Hypotension & Spine Principles
09:15 - 09:30 am Damage Control Resuscitation 2025:
TXA 2g Bolus; The Lethal Diamond
(Hypocalcaemia); MTP Ratios &
Fibrinogen — Updated Evidence
09:30 - 09:45 am TRIAL UPDATE:
CRYOSTAT-2 (JAMA 2023) — Empirical
Cryoprecipitate in Major Haemorrhage:
Does Early Fibrinogen Replacement
Change Outcomes? Implications for
Indian MTP
09:45 - 10:00 am REBOA After UK-REBOA (2023) —
Resuscitative Endovascular Balloon
Occlusion: Current Evidence, Patient
Selection & Why It Is Not Routine
Practice
10:00 - 10:15 am Physiologically difficult Airway Concept,
Whats new in DAS - 2025 &
AIDAA 2025 Guidelines
10:15 - 10:20 am Discussion (Q&A)
SESSION 2 — RESUSCITATION MEDICINE: AHA 2025 & LANDMARK TRIALS
09:15 - 10:30 am AHA CPR & ECC Guidelines 2025 —
What Every Emergency Physician
Must Know: Unified Chain of Survival;
Mechanical CPR Devices De-listed;
Post-Arrest Temp Targets
10:30 - 10:45 am Post-Cardiac Arrest Care 2025 —
Beyond ROSC: Coronary Angio Timing,
Targeted Temperature Management
Revision, Neuroprognostication &
Post-Arrest Myoclonus
10:45 - 11:00 am ECPR — Extracorporeal CPR in India:
When to Consider It, Feasibility,
Evidence & Setting Up an
ECMO-Capable Cardiac Arrest Pathway
11:00 - 11:15 am Traumatic Cardiac Arrest — A Different
Beast: Modified CPR Algorithms,
Reversible Causes, Resuscitative
Thoracotomy Indications & Survival
Data
11:15 - 11:20 am Discussion (Q&A)
SESSION 3 — CARDIOLOGY EMERGENCIES: NEW EVIDENCE 2026
11:30 - 11:45 am STEMI Management 2025 —
Primary PCI vs Pharmacoinvasive
Strategy in India: Door-to-Balloon
Targets, Late Presenters & Updated
Algorithm for Resource-Limited Settings
11:45 - 12:00 pm TRIAL UPDATE:
DanGer Shock Trial (NEJM 2024/2025)
Impella CP in STEMI Cardiogenic
Shock:16.3% Absolute Mortality
Reduction at 10 Years; ACC/AHA
Class 2a — Changing How We
Escalate Shock
12:00 - 12:15 pm Cardiogenic Shock in the ED 2026 —
SCAI Classification, Vasopressor
Selection,Inotropes, MCS Devices &
the 'Shock Team' Concept: A Practical
ED Framework
12:15 - 12:30 pm Emergency Arrhythmia Management
2026 —AF in the ED: Rate vs Rhythm,
Anticoagulation Timing; VT/VF; Updated
Cardioversion & Drug Doses
12:30 - 12:45 pm Acute Decompensated Heart Failure in
the ED 2026 —NIV-First Strategy,
Vasodilators, Diuretic Dosing & When
to Escalate: Evidence-Based Approach
12:45 - 01:00 pm Inauguration, Lamp Lighting,
Release of Souvenir Book,
Chief Guest Address
01:00 - 01:05 pm Discussion (Q&A)
01:05 - 02:00 pm LUNCH BREAK & POSTER PRESENTATION
SESSION 4 — NEUROLOGICAL EMERGENCIES: UPDATES & LANDMARK TRIALS
02:00 - 02:15 pm Acute Ischaemic Stroke 2026 —
Thrombolysis Window Expansion,
Tenecteplase vs Alteplase,
Perfusion Imaging in Late Window &
'Time is Brain' in the Indian ED
02:15 - 02:30 pm Mechanical Thrombectomy (EVT) for
Stroke — Building the Stroke Pathway:
ED Workflow, Transfer Protocols,
Time Targets & Access Challenges in
Tier-2 India
02:30 - 02:45 pm TRIAL UPDATE:
OPTIMAS Trial (Lancet 2024) —
Early DOAC After AF-Related Stroke:
Initiating Anticoagulation within 4 Days
Is Non-Inferior & Safe; This Changes
the ED Discharge Decision
02:45 - 02:50 pm Discussion (Q&A)
SESSION 5 — RESPIRATORY EMERGENCIES: EVIDENCE-BASED UPDATES
02:50 - 03:05 pm NIV & HFNO in the ED 2026 —
CPAP vs BiPAP vs High-Flow Nasal
Oxygen: Who Gets What, When to
Escalate, Failure Criteria & Evidence
for Each Device
03:05 - 03:20 pm Emergency Mechanical Ventilation for
the Non-Intensivist:Initial Settings,
Lung-Protective Strategy, PEEP
Titration, Driving Pressure & Common
ED Mistakes
03:20 - 03:35 pm Massive Pulmonary Embolism in the
ED 2026 —Risk Stratification,
Systemic Thrombolysis vs
Catheter-Directed Therapy &
ED Decision Algorithm
03:35 - 03:40 pm Discussion (Q&A)
SESSION 6 — SEPSIS & CRITICAL CARE: SSC 2026 & PRACTICE-CHANGING EVIDENCE
03:40 - 03:55 pm Surviving Sepsis Campaign 2026 —
129 Recommendations, 46 New:
Top 10 Changes That Immediately
Affect ED & ICU Practice in India
03:55 - 04:10 pm Vasopressors in Septic Shock 2026 —
Noradrenaline, Vasopressin,
Angiotensin II & Methylene Blue:
New Trial Evidence & Drug Choice
Algorithm
04:10 - 04:25 pm TRIAL UPDATE:
Pro-Can Study (2024) — PCT-Guided
Antibiotic De-escalation in Sepsis:
Safe to Stop Antibiotics Based on
Procalcitonin; Antimicrobial Stewardship
in the ICU/ED
04:25 - 04:30 pm Discussion (Q&A)
SESSION 7 — INFECTIOUS DISEASE EMERGENCIES: EM-RELEVANT UPDATES 2024–2026
04:45 - 05:00 pm Antimicrobial Stewardship in the
ED 2026 —Right Drug, Right Dose,
Right Duration: Practical Guidelines
for De-escalation & Culture-Directed
Therapy
05:00 - 05:15 pm Emerging Infections & Outbreak
Preparedness —Mpox, H5N1 Avian
Influenza, Nipah: ED Recognition,
PPE Protocols & Hospital Escalation
Algorithms
05:15 - 05:20 pm Discussion (Q&A)
SESSION 8 — EMERGENCY TOXICOLOGY: INDIA-RELEVANT UPDATES 2024–2026
05:15 - 05:30 pm AHA Toxicology-Focused Resuscitation
Update 2023 —Cardiac Arrest from
Poisoning: Modified CPR, Prolonged
Resuscitation, Lipid Emulsion &
ECMO in Toxicology
05:30 - 05:45 pm TRIAL UPDATE:
Pralidoxime Meta-Analysis (2024) —
The Landmark Controversy:
Atropine + Pralidoxime Associated
with HIGHER Mortality vs Atropine
Alone in OP Poisoning; Should India
Stop Using Pralidoxime?
05:45 - 06:00 pm Snakebite Envenomation 2025–2026 —
Global Guideline Revision:
Antivenom Dosing in India,
Coagulopathy Management,
Neuro Toxicity & Central India Clinical
Realities
06:00 - 06:05 pm Discussion (Q&A)
06:05 - 06:20 pm Best Paper Award,
Best Poster Award,
Vote of Thanks & Valedictory Function
06:20 - 06:30 pm
Scroll to Top